Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

NCT06483945 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-07-03

No results posted yet for this study

Summary

"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"

Conditions

Interventions

DEVICE

Dexcom CGM G6/G6 Pro/G7

Dexcom CGM G6/G6 Pro/G7 device

Sponsors & Collaborators

  • DexCom, Inc.

    lead INDUSTRY

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-28
Primary Completion
2028-03-31
Completion
2028-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06483945 on ClinicalTrials.gov